{
  "id": 20723365,
  "title": "Centre proposes separate licensing framework for wholesale trade of bulk drugs",
  "url": "https://urgent.news/2026/11/19/centre-proposes-separate-licensing-framework-for-wholesale-trade-of",
  "topic": "world",
  "section": "World",
  "published": "2026-11-19T08:15:45.000Z",
  "source": {
    "name": "Hindustan Times",
    "slug": "hindustan-times",
    "url": "https://www.hindustantimes.com/india-news/centre-proposes-separate-licensing-framework-for-wholesale-trade-of-bulk-drugs-101795076146063.html"
  },
  "original_language": "en",
  "account": "New Delhi - The Health and Family Welfare Ministry has proposed a distinct licensing system for the wholesale trade of bulk drugs, aiming to enhance regulatory control and accountability within the pharmaceutical supply chain. The suggested changes to the 1945 Drugs Rules propose separate forms for bulk drug wholesale applications and licenses, distinct from the existing provisions for formulated products. Currently, a unified license applies to both bulk drugs and formulations. The ministry highlighted that this approach would enable more targeted oversight of the wholesale trade for bulk drugs, ensuring greater accountability in the distribution and handling of these substances. The proposal was endorsed by both the Drugs Consultative Committee and the Drugs Technical Advisory Board during their respective meetings in November 2025 and February 2026. Under the new framework, the license would encompass the categories of bulk drugs traded by wholesalers, including those regulated under the Narcotic Drugs and Psychotropic Substances Act of 1985. The ministry emphasized that the sale of bulk drugs would be overseen by a qualified individual, thereby bolstering accountability in the sector. Upon implementation, the amendment is expected to provide improved control over the wholesale of bulk drugs, thereby reinforcing enforcement measures concerning antimicrobial resistance and the movement of NDPS drugs. The ministry assured that existing licensees would be granted sufficient time to adapt to the new requirements, with compliance becoming mandatory upon the expiry of their current retention period or 12 months after the final publication of the amendment, whichever occurs later. The ministry has given stakeholders and the public a window of 30 days to submit objections or suggestions upon the release of the draft rules in the Gazette.",
  "summary": null,
  "key_points": [
    "Health Ministry proposes separate licensing system for bulk drug wholesale trade.",
    "Distinct forms for bulk drug applications and licenses proposed, separate from formulated products.",
    "New framework to enhance accountability in bulk drug distribution and NDPS drug movement."
  ],
  "editors_take": "Decoupling bulk drug licensing from formulated products shifts the regulatory focus toward specialized oversight to tighten control over pharmaceutical supply chains and curb the movement of restricted substances.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}